MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

NCT06050707 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Anal Squamous Cell Carcinoma

Interventions

RADIATION: Radiotherapy - Low risk group
RADIATION: Radiotherapy - Standard risk group
RADIATION: Radiotherapy - Intermediate risk group
RADIATION: Radiotherapy - High risk group

Sponsor

University Health Network, Toronto

Collaborators

[object Object]